当前位置: 首页 >> 检索结果
1141. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.
Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer.
1143. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis.
作者: Woojin Lew.;Madhukar Pai.;Olivia Oxlade.;Daniel Martin.;Dick Menzies.
来源: Ann Intern Med. 2008年149卷2期123-34页
Despite the increasing prevalence of drug-resistant tuberculosis, most low- and middle-income countries use standardized regimens, without assessment of drug susceptibility.
1144. Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis.
作者: Rosario Gonzalez.;Javier Zamora.;Judith Gomez-Camarero.;Luis-Miguel Molinero.;Rafael Bañares.;Agustín Albillos.
来源: Ann Intern Med. 2008年149卷2期109-22页
Combining endoscopic therapy and beta-blockers may improve outcomes in patients with cirrhosis and bleeding esophageal varices.
1145. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.
Interferon-gamma-release assays (IGRAs) are alternatives to the tuberculin skin test (TST). A recent meta-analysis showed that IGRAs have high specificity, even among populations that have received bacille Calmette-Guérin (BCG) vaccination. Sensitivity was suboptimal for TST and IGRAs.
1146. Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement.
Reaffirmation of the 2004 U.S. Preventive Services Task Force recommendation statement about screening for asymptomatic bacteriuria in adults.
1147. Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement.
Asymptomatic bacteriuria is common, and screening for this condition in pregnant women is a well-established, evidence-based standard of current medical practice. Screening other groups of adults has not been shown to improve outcomes.
1149. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events.
作者: Eric Bateman.;Harold Nelson.;Jean Bousquet.;Kenneth Kral.;Laura Sutton.;Hector Ortega.;Steven Yancey.
来源: Ann Intern Med. 2008年149卷1期33-42页
Recent analyses have suggested an increased risk for serious asthma-related adverse events in patients receiving long-acting beta-agonists.
1150. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.
作者: Susan L Norris.;Devan Kansagara.;Christina Bougatsos.;Rongwei Fu.; .
来源: Ann Intern Med. 2008年148卷11期855-68页
More than 19 million Americans are affected by type 2 diabetes mellitus, which is undiagnosed in one third of these persons. In addition, it is estimated that more than 54 million adults have prediabetes. Debate continues over the benefits and harms of screening and then treating adults who have asymptomatic diabetes or prediabetes.
1151. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement.
Updated U.S. Preventive Services Task Force (USPSTF) recommendation about screening for type 2 diabetes mellitus in adults.
1152. In the clinic. Hepatitis C.
Chronic hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States, with an estimated overall prevalence of 3.2 million persons (1.3%) and prevalence peaks between age 40 to 49 years (1). The worldwide prevalence of HCV infection is even higher at 2.0%, corresponding to 140 million persons (2). In terms of complications, cirrhosis due to HCV disease is the most frequent indication for liver transplantation in the United States (3), and the overall incidence of hepatocellular carcinoma, a complication of HCV cirrhosis, continues to increase at alarming rates. In an evaluation of population-based registries of the Surveillance, Epidemiology, and End Results (SEER) program in the United States, the overall age-adjusted incidence rates of hepatocellular carcinoma increased from 1.4 per 100 000 in 1975 to 1977 to 3.0 per 100 000 in 1996 to 1998 (4).
1153. Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force.
作者: Teresa A Hillier.;Kimberly K Vesco.;Kathryn L Pedula.;Tracy L Beil.;Evelyn P Whitlock.;David J Pettitt.
来源: Ann Intern Med. 2008年148卷10期766-75页
In 2003, the U.S. Preventive Services Task Force concluded that evidence was insufficient to advise for or against routinely screening all pregnant women for gestational diabetes mellitus.
1154. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.
Update of 2003 U.S. Preventive Services Task Force (USPSTF) recommendation about screening for gestational diabetes.
1155. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.
作者: Nicolas Ochs.;Reto Auer.;Douglas C Bauer.;David Nanchen.;Jacobijn Gussekloo.;Jacques Cornuz.;Nicolas Rodondi.
来源: Ann Intern Med. 2008年148卷11期832-45页
Data on the association between subclinical thyroid dysfunction and coronary heart disease (CHD) and mortality are conflicting.
1156. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.
Standard proton-pump inhibitor-based therapy for Helicobacter pylori infection fails in up to one quarter of patients. Sequential therapy may be more efficacious.
1157. Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline.
作者: Hau Liu.;Neil M Paige.;Caroline L Goldzweig.;Elaine Wong.;Annie Zhou.;Marika J Suttorp.;Brett Munjas.;Eric Orwoll.;Paul Shekelle.
来源: Ann Intern Med. 2008年148卷9期685-701页
Screening for low bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is the primary way to identify asymptomatic men who might benefit from osteoporosis treatment. Identifying men at risk for low BMD and fracture can help clinicians determine which men should be tested.
1158. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians.
作者: Amir Qaseem.;Vincenza Snow.;Paul Shekelle.;Robert Hopkins.;Mary Ann Forciea.;Douglas K Owens.; .
来源: Ann Intern Med. 2008年148卷9期680-4页
The American College of Physicians developed this guideline to present the available evidence on risk factors and screening tests for osteoporosis in men.
1159. Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
作者: Ellen Warner.;Hans Messersmith.;Petrina Causer.;Andrea Eisen.;Rene Shumak.;Donald Plewes.
来源: Ann Intern Med. 2008年148卷9期671-9页
A sensitive and acceptable screening regimen for women at high risk for breast cancer is essential. Contrast-enhanced magnetic resonance imaging (MRI) of the breast is highly sensitive for diagnosis of breast cancer but has variable specificity.
1160. Narrative review: buprenorphine for opioid-dependent patients in office practice.
The profile of opioid dependence in the United States is changing. Abuse of prescription opioids is more common than that of illicit opioids: Recent data indicate that approximately 1.6 million persons abuse or are dependent on prescription opioids, whereas 323,000 abuse or are dependent on heroin. Despite this prevalence, nearly 80% of opioid-dependent persons remain untreated. One option for expanding treatment is the use of buprenorphine and the buprenorphine-naloxone combination. Buprenorphine is a partial opioid agonist that can be prescribed by trained physicians and dispensed at pharmacies. This article addresses the clinical presentation of a patient with opioid dependence and describes the relatively new practice of office-based treatment with buprenorphine-naloxone. The different components of treatment; the role of the physician who provides this treatment; and the logistics of treating this growing, multifaceted patient population are also examined.
|